Levetiracetam Zentiva

Levetiracetam, the active ingredient in Levetiracetam Zentiva, is an anticonvulsant presented as an injectable solution for intravenous use. It is employed as adjunctive therapy for partial‑onset, generalized tonic‑clonic and myoclonic seizures in patients who require additional seizure control.

GNH USA supplies Levetiracetam Zentiva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Levetiracetam is an antiepileptic drug used to manage several seizure types.

- Partial‑onset seizures: reduces seizure frequency as adjunctive therapy. - Generalized tonic‑clonic seizures: provides additional seizure control when combined with other agents. - Myoclonic seizures: helps decrease the occurrence of myoclonic episodes as part of combination treatment.

Levetiracetam may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Dizziness - Fatigue - Somnolence - Headache - Irritability - Nausea

Serious or Rare Side Effects: - Severe skin reactions such as Stevens‑Johnson syndrome - Depression or suicidal thoughts - Severe allergic reactions (anaphylaxis) - Blood dyscrasias (e.g., neutropenia) - Respiratory depression in vulnerable patients

When using Levetiracetam, consider the following safety measures: - Renal impairment: adjust dose based on renal function. - Hepatic impairment: monitor liver enzymes and clinical response. - Psychiatric disorders: observe for mood changes or depression. - Concomitant CNS depressants: may increase sedation; monitor closely. - Pregnancy: category unknown; use only if benefit outweighs potential risk. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Levetiracetam has a relatively low interaction profile, but certain drug combinations require attention.

Major Interactions (Avoid): - Strong enzyme‑inducing antiepileptics (e.g., carbamazepine, phenobarbital): may lower levetiracetam levels. - Live attenuated vaccines: increased risk of infection.

Moderate Interactions (Monitor Closely): - Sedative CNS depressants (benzodiazepines, opioids): may enhance sedation. - Antidepressants (SSRIs, SNRIs): monitor for mood alterations. - Antacids containing aluminum or magnesium: may affect absorption when oral formulations are used.